Ursolic Acid Triggers Apoptosis in Human Osteosarcoma Cells via Caspase Activation and the ERK1/2 MAPK Pathway

• Published in: Journal of agricultural and food chemistry Vol. 64; no. 21; pp. 4220 - 4226
• Main Authors: Wu, Chia-Chieh, Cheng, Chun-Hsiang, Lee, Yi-Hui, Chang, Ing-Lin, Chen, Hsin-Yao, Hsieh, Chen-Pu, Chueh, Pin-Ju
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 01.06.2016
• Subjects: Apoptosis - drug effects; Bone Neoplasms - enzymology; Bone Neoplasms - genetics; Bone Neoplasms - metabolism; Bone Neoplasms - physiopathology; Caspase 3 - genetics; Caspase 3 - metabolism; Caspase 8 - genetics; Caspase 8 - metabolism; Caspase 9 - genetics; Caspase 9 - metabolism; Cell Line, Tumor; Humans; MAP Kinase Signaling System - drug effects; Mitogen-Activated Protein Kinases - genetics; Mitogen-Activated Protein Kinases - metabolism; Osteosarcoma - enzymology; Osteosarcoma - genetics; Osteosarcoma - metabolism; Osteosarcoma - physiopathology; Triterpenes - pharmacology; Ursolic Acid; apoptosis; MG-63 cells; MAPK; ursolic acid; caspase
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.6b00542

Ursolic acid (UA), a naturally occurring pentacyclic triterpene acid found in many medicinal herbs and edible plants, has been shown to trigger apoptosis in several lines of tumor cells in vitro. We found that treatment with UA suppressed the viability of human osteosarcoma MG-63 cells and induced cell cycle arrest at sub-G1 and G2/M phases. Furthermore, exposure to UA induced intracellular oxidative stress and collapse of mitochondrial membrane permeability, resulting in the subsequent activation of apoptotic caspases 8, 9, and 3 as well as PARP cleavage, and ultimately apoptosis in MG-63 cells. Moreover, protein analysis of mitogen-activated protein kinase (MAPK)-related protein expression showed an increase in activated ERK1/2, JNK, and p38 MAPK in UA-treated MG-63 cells. In addition, UA-induced apoptosis was significantly abolished in MG-63 cells that had been pretreated with inhibitors of caspase 3, 8, and 9 and ERK1/2. Furthermore, UA-treated MG-63 cells also exhibited an enhancement in Bax/Bcl-2 ratio, whereas anti-apoptotic XIAP and survivin were down-regulated. Taken together, we provide evidence demonstrating that UA mediates caspase-dependent and ERK1/2 MAPK-associated apoptosis in osteosarcoma MG-63 cells.